Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIg withdrawal versus continuation in stable CIDP
NL-OMON45047Phase 4Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Apr 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of immune globulin and sodium chloride in chronic inflammatory demyelinating polyneuropathy (CIDP) and inflammatory neuropathy (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Rasch-Overall Disability Scale. Started Apr 2014; status: active, not recruiting.
02
Drugs
immune globulinsodium chloride
03
Conditions
chronic inflammatory demyelinating polyneuropathy (CIDP)inflammatory neuropathy
Beyond the preview
Go deeper on NL-OMON45047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45047.